Anti-atherogenic effects of resveratrol via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1 in macrophages

Resveratrol (RSV), a phenolic component, is found in grape skins, peanuts, pistachios and red wine. RSV has protective activities in atherosclerosis, yet the detailed mechanisms are not fully elucidated. In the present study, we observed that RSV inhibited oxLDL-mediated lipid accumulation through the enhancement of cholesterol efflux in THP-1-derived macrophages and explored the possible underlying mechanisms. RSV dose-dependently enhanced the mRNA and protein levels of ATP-binding membrane cassette transporters A1 and G1 (ABCA1 and ABCG1) but had no effect on the mRNA expression of scavenger receptor class BI (SR-BI) in cholesterol homeostasis. Additionally, the functional inhibition of ABCA1 and ABCG1 with short hairpin RNA abrogated the effects of RSV on lipid accumulation. The upregulation of ABCA1 and ABCG1 by RSV depended on LXRα, as evidenced by an increase in the nuclear levels of LXRα through the induction of nuclear translocation. The functional inhibition of LXRα with a pharmacological inhibitor, geranylgeranyl pyrophosphate (GGPP), abolished the RSV-mediated protective effects in macrophages. These findings suggest that LXRα-dependent upregulation of ABCA1 and ABCG1 might mediate the beneficial effects of RSV, which ameliorated the oxLDL-mediated lipid accumulation in the process of lipid-laden foam cells formation.

► Resveratrol attenuates lipid accumulation by elevating cholesterol efflux.
► Resveratrol upregulates the transcription level of ABCA1 and ABCG1.
► Resveratrol induces the nuclear translocation and activation of LXRα.
► An LXRα-dependent pathway is involved in the anti-atherogenic effects of resveratrol.